aod9604 half life pharmacokinetics Onset 💉 Peptide Timing Matters: Why

Protocol: AOD 9604: 500mcg morning fasted Semaglutide: Standard titration protocol (start low, increase gradually) This combination requires closer monitoring since you're affecting multiple metabolic pathways

All products sold by Regentide are for laboratory and research use only (RUO)

Reported to act on fat-cell metabolism without stimulating IGF-1 production, distinguishing it from full GH in preclinical work

It is administered as a small subcutaneous injection, typically once daily, and is most often deployed in 6 to 12 week structured cycles under medical supervision

While early research and anecdotal evidence suggest positive results, its long-term safety profile remains unclear due to limited human clinical trials